Skip to main content
Clinical Trials/NL-OMON27604
NL-OMON27604RecruitingNot Applicable

Development of a new 3D virtual desktop imaging technique for real time non-invasive evaluation of the utero-placental interface vascularization throughout pregnancy (VIRTUAL).

Erasmus University Medical Center Rotterdam, the Netherlands0 sites520 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
Not Applicable
Status
Recruiting
Sponsor
Enrollment
520

Study Overview

Brief Summary

IF Reijnders, AGMGJ Mulders, MPH Koster, AHJ Koning, A Frudiger, SP Willemsen, E Jauniaux, GJ Burton, RPM Steegers-Theunissen, EAP Steegers. New imaging markers for preconceptional and first-trimester utero-placental vascularization. Accepted, Placenta, October 2017.

Study Design

Study Type
Observational

Eligibility Criteria

Inclusion Criteria

  • 1)Women aged between 18 years or older and 45 years or below, planning a pregnancy or < 10 weeks pregnant.
  • 2)Understanding of Dutch language in speaking and reading.

Exclusion Criteria

  • A potential subject who meets any of the following criteria will be excluded from participation in this study:
  • 1)Women unable or unwilling to give informed consent.

Investigators

Sponsor
Erasmus University Medical Center Rotterdam, the Netherlands

Similar Trials

Development of a new 3D virtual desktop... | Clinical Trial